Scientists at Columbia University have discovered that metformin, a common and inexpensive diabetes drug, may help treat ...
CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...
The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted ...
Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have ...
Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the ...
Why are women more prone to Alzheimer's and multiple sclerosis? A UCLA study reveals an X-linked gene causing brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback